Table 2.
Laboratory and Clinical Characteristics of the Study Population
| Laboratory and Clinical Characteristics | Frequency/Mean | Died | Survived | χ2 | P-value |
|---|---|---|---|---|---|
| Glucose | |||||
| Hypoglycemia | 109.67±53.73 | 2(28.6%) | 5(71.4%) | 2.010 | 0.366 |
| Normal | 6(12.5%) | 42(87.5%) | |||
| Hyperglycemia | 2(8.3%) | 22(91.7%) | |||
| AST | 0.461 | 0.395 | |||
| Normal | 216.91±445.3 | 2(8.7%) | 21(91.3%) | ||
| Abnormal | 8(14.3%) | 48(85.7%) | |||
| ALT | 1.950 | 0.145 | |||
| Normal | 146.29±268.77 | 3(7.5%) | 37(92.5%) | ||
| Abnormal | 7(17.9%) | 32(82.1%) | |||
| Urea (mg/dL) | 0.611 | 0.575 | |||
| Normal | 136.37±85.95 | 0(0.0%) | 4(100.0%) | ||
| Abnormal | 10(13.3%) | 65(86.7%) | |||
| Sodium (mmol/L) | 3.387 | 0.184 | |||
| Low Sodium | 129.56±13.34 | 8(13.6%) | 51(86.4%) | ||
| Normal | 1(5.6%) | 17(94.4%) | |||
| High Sodium | 1(50.0%) | 1(50.0%) | |||
| Potassium (mmol/L) | 3.016 | 0.221 | |||
| Low Potassium | 10.15±47.40 | 1(14.3%) | 6(85.7%) | ||
| Normal | 4(8.0%) | 46(92.0%) | |||
| High Potassium | 5(22.7%) | 17(77.3%) | |||
| Uric Acid | 7.626 | 0.022* | |||
| Low Uric acid | 9.51±3.08 | 1(100.0%) | 0(0.0%) | ||
| Normal | 2(7.4%) | 25(92.6%) | |||
| High Uric Acid | 7(13.7%) | 44(86.3%) | |||
| Albumin | 0.774 | 0.679 | |||
| Low Albumin | 2.86±2.42 | 10(13.5%) | 64(86.5%) | ||
| Normal | 0(0.0%) | 2(100.0%) | |||
| High Albumin | 0(0.0%) | 3(100.0%) | |||
| CPR | 1.113 | 0.372 | |||
| Normal | 76.46±56.79 | 0(0.0%) | 7(100.0%) | ||
| Abnormal | 10(13.9%) | 62(86.1%) | |||
| Platelet | 8.725 | 0.013* | |||
| Low Platelet | 4(12.9%) | 27(87.1%) | |||
| Normal | 3(7.1%) | 39(92.9%) | |||
| High platelet | 3(50.0%) | 3(50.0%) | |||
Note: *P-values < 0.05 are statistically significant.
Abbreviations: SD, standard deviation; ALT, Alanine transaminase; AST, Aspartate transaminase; CRP, C-reactive protein.